Table 5. Grading of recommendations, assessment, development and evaluation (GRADE) evidence quality ratings for survival outcomes.
The quality of evidence assessments was performed using Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system [22]. Abbreviations: SRS = stereotactic radiosurgery.
Median survival | Six-month survival | 12-month survival | |
Studies demonstrating significant improvement | 2/4 | 2/4 | 2/4 |
SRS and Ipilimumab patients | 89 | 89 | 89 |
SRS alone patients | 133 | 133 | 133 |
Initial quality of evidence | Low (two plus) | Low (two plus) | Low (two plus) |
Risk of bias | Serious (-1) | Serious (-1) | Serious (-1) |
Inconsistency | Not serious | Not serious | Not serious |
Indirectness | Not serious | Not serious | Not serious |
Imprecision | Serious (-1) | Serious (-1) | Serious (-1) |
Publication bias | Not likely | Not likely | Not likely |
Large effect | Large (+1) | Large (+1) | Large (+1) |
Dose response | No gradient | No gradient | No gradient |
All plausible residual confounding | Would reduce effect (+1) | Would reduce effect (+1) | Would reduce effect (+1) |
GRADE overall quality of evidence | Low (two plus) | Low (two plus) | Low (two plus) |